Referenser för Femarelle

Publ-år

 PDF - filer

1. Somjen D, Yoles I, et al. DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus. 
J Steroid Biochemistry & Molecular Biology 2003; 86(1): 93-98.

 2003

Hämta abstrakt här

2. Yoles I, et al. Tofupill/Femarelle (DT56a) - a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss.
Menopaus 2003; 10(6): 522-525.

 2003

Hämta abstrakt här

3. Yoles I et al. Efficacy and safety of standard versus low dose of Femarelle (D56a) for the treatment of
menopausal symptoms. 
J Clin Exp Obstet Gynecol 2004; 31(2): 123-126.

 2004

Hämta abstrakt här

4. Oropeza MV, Orozco S, Ponce H, Campos MG. Tofupill lacks peripheral estrogen-like actions in the rat
reproductive tract.  
Reprod Toxicol 2005; 20(2): 261-266.

 2005

Hämta abstrakt här

5. Somjen D et al. DT56a (Femarelle/Tofupill) stimulates bone formation in female rats. 
British J Obstetrics & Gynecology 2005; 112(7): 981-985.

 2005

Hämta abstrakt här

6. Somjen D, Katzburg S, Lieberherr M, Hendel D, Yoles I. DT56a stimulates gender-specific human cultured bone cells
In Vitro.
J Steroid Biochemistry & Molecular Biology 2006; 98(1): 90-96.

 2006

Hämta abstrakt här

7. Somjen D, Yoles I. DT56a (Femarelle): A Natural Selective Estrogen Receptor Modulator (SERM).  
J Steroid Biochemistry & Molecular Biology 2007; 104: 252-258.

 2007

Hämta abstrakt här

8. Yoles I & Liling G. Pharmacological Doses of the Natural Phyto-SERM DT56a (Femarelle) have no Effect on
MCF-7 Breast Cancer Cell-line.
European J Obstetrics & Gynecology and Reproductive Biology 2007; 130(1): 140-141.

 2007

Hämta "letter to the editor" här

9. Nachtingall MJ et al. The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity
in normal or thrombophilic postmenopausal women.
Menopause: 2011, Mar; 18(3): 285 - 8..

 2011

Hämta abstrakt här

10. Yoles I. Femarelle för the management of Menopause: from Cell Receptors to the Patient.
J Gynecological Endocrinology 2008.

 2008

Inte tillgänglig ännu

11. Pluchino N, Merlini S, Cubeddu A, et al. Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats.
Menopause: The J of the North Am Menopause Soc, vol 16, no 5, pp. 1037-1043.

 2009

 Hämta artikeln i full-text här

12. Bedell S, Nachtigall M, Naftolin F. The pros and cons of plant estrogens for menopause.
J Steroid Biochem Mol Biol 2013.

 2013

 Hämta artikeln här

13. Labos G et al. Efficacy and safety of DT56a (Femarelle) compared to hormone therapy in Greek postmenopausal women.
J Endocrinol Invest 2013, Apr 8.

 2013

 Hämta artikeln här